Severe Hepatitis Intervention With Emapalumab for Liver Disease

NCT07744919 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis

Interventions

DRUG: Emapalumab

Sponsor

Children's Healthcare of Atlanta

Collaborators

[object Object]